Description of Tabula Rasa Healthcare Inc's Business Segments
Tabula Rasa Healthcare Inc is a prominent healthcare technology company specializing in enhancing medication management processes to improve patient care outcomes. The company employs cutting-edge software tools and clinical consulting services that focus on creating personalized medication regimens tailored to the unique needs of individual patients.
Segments:
1. Medication Risk Mitigation: Tabula Rasa Healthcare Inc prioritizes the reduction of medication-related risks through a robust medication safety platform. This platform seamlessly integrates with electronic health records (EHR) systems and other healthcare IT solutions. The goal is to minimize drug interactions, adverse drug reactions, and other complications associated with medication use. By addressing these risks, the company aims to enhance patient safety and overall health outcomes, fostering a healthcare environment where medication use is closely monitored and adjusted to individual patient profiles.
2. Precision Pharmacotherapy: Leveraging its proprietary Medication Risk Mitigation technology, the company empowers healthcare providers to make informed, evidence-based medication decisions. This is particularly facilitated by the use of pharmacogenomics tests, which analyze patients genetic information to provide customized drug recommendations. By understanding how patients metabolize different medications based on their genetic profiles, Tabula Rasa helps to eradicate the traditional trial-and-error approach in prescribing medications, thus promoting greater medication adherence and optimal therapeutic results.
Products:
1. MedWise Advisor: MedWise Advisor serves as Tabula Rasas flagship product, uniquely integrating pharmacogenomics, medication management, and clinical decision support technologies. It functions to optimize medication regimens by alerting healthcare providers to potential risks, such as drug-drug interactions and drug-gene interactions. Through this proactive approach, MedWise Advisor aids providers in ensuring that patients receive safe and effective medication therapy tailored to their specific circumstances.
2. DoseMeRx: DoseMeRx is an innovative precision dosing tool designed to offer personalized drug dosing recommendations. It employs advanced mathematical modeling to analyze patients’ clinical and demographic data, ensuring that dosing regimens are accurately tailored to achieve therapeutic goals. This tool is particularly beneficial in managing the care of critically ill patients, where achieving the correct dosage is crucial for avoiding adverse drug events and ensuring effective treatment.
Services:
1. Medication Regimen Review: The company offers comprehensive medication regimen review services, wherein expert teams conduct an in-depth assessment of patients current medication therapies. This review scrutinizes medication histories, identifies potential drug interactions, mitigates adverse drug events, and evaluates overall medication-related risks. By conducting these thorough reviews, Tabula Rasa helps healthcare providers enhance the safety and efficacy of their prescribing practices.
2. Pharmacogenomics Testing: Tabula Rasa Healthcare Inc provides pharmacogenomics testing services that investigate patients genetic profiles. This testing identifies genetic variants that influence how individuals metabolize various drugs, allowing for more informed and personalized medication decisions. By providing healthcare providers with insights into how a patient is likely to respond to certain medications, these services contribute significantly to creating safer and more effective treatment plans.
Summary: In essence, Tabula Rasa Healthcare Inc stands at the forefront of medication management innovation, equipping healthcare providers with the necessary tools and services to enhance patient safety and treatment effectiveness. Through its focus on medication risk mitigation and precision pharmacotherapy, alongside its flagship products—MedWise Advisor and DoseMeRx—and its comprehensive suite of services, including medication regimen reviews and pharmacogenomics testing, the company is dedicated to delivering a high standard of personalized care for patients across various healthcare settings.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
